{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720087",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720087_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">Fluvastatin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the anticoagulant effect of</ph> <ph otherprops=\"acenocoumarol\" outputclass=\"int-drug\">acenocoumarol</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor INR and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fluvastatin   increases   the anticoagulant effect of   acenocoumarol .  Manufacturer advises monitor INR and adjust dose .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acenocoumarol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720088",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720088_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"alcohol (beverage)\" outputclass=\"int-drug\">alcohol (beverage)</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  alcohol (beverage)  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alcohol (beverage)</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720089",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720089_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"alectinib\" outputclass=\"int-drug\">alectinib</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  alectinib  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alectinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720090",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720090_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"amiodarone\" outputclass=\"int-drug\">Amiodarone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Amiodarone   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amiodarone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720091",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720091_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"asparaginase\" outputclass=\"int-drug\">asparaginase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  asparaginase  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Asparaginase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720092",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720092_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"bedaquiline\" outputclass=\"int-drug\">bedaquiline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  bedaquiline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bedaquiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720093",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720093_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"bezafibrate\" outputclass=\"int-drug\">Bezafibrate</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Bezafibrate   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bezafibrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720094",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720094_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">carbamazepine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  carbamazepine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carbamazepine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720095",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720095_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ceftobiprole\" outputclass=\"int-drug\">Ceftobiprole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ceftobiprole   is predicted to   increase   the concentration of   fluvastatin .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ceftobiprole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720096",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720096_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ciclosporin\" outputclass=\"int-drug\">Ciclosporin</ph> <ph outputclass=\"int-magnitude\">moderately</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ciclosporin   moderately   increases   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciclosporin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720097",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720097_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ciprofibrate\" outputclass=\"int-drug\">Ciprofibrate</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ciprofibrate   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciprofibrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720098",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720098_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"clavulanic acid\" outputclass=\"int-drug\">clavulanic acid</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  clavulanic acid  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clavulanic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720099",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720099_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"colchicine\" outputclass=\"int-drug\">Colchicine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Colchicine   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Colchicine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720100",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720100_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"crisantaspase\" outputclass=\"int-drug\">crisantaspase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  crisantaspase  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Crisantaspase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720101",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720101_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"dactinomycin\" outputclass=\"int-drug\">dactinomycin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  dactinomycin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dactinomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720102",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720102_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"dantrolene\" outputclass=\"int-drug\">dantrolene</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  dantrolene  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dantrolene</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720103",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720103_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">Fluvastatin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"daptomycin\" outputclass=\"int-drug\">daptomycin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fluvastatin   is predicted to   increase   the risk of rhabdomyolysis when given with   daptomycin .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Daptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720104",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720104_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"demeclocycline\" outputclass=\"int-drug\">demeclocycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  demeclocycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Demeclocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720105",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720105_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"didanosine\" outputclass=\"int-drug\">didanosine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  didanosine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Didanosine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720106",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720106_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"doxycycline\" outputclass=\"int-drug\">doxycycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  doxycycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doxycycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720107",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720107_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"elbasvir\" outputclass=\"int-drug\">Elbasvir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/fluvastatin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP1636\">fluvastatin</xref></ph> dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Elbasvir   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises adjust  fluvastatin  dose .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Elbasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720108",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720108_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"eltrombopag\" outputclass=\"int-drug\">Eltrombopag</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Eltrombopag   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Eltrombopag</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720109",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720109_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ezetimibe\" outputclass=\"int-drug\">Ezetimibe</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ezetimibe   potentially   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ezetimibe</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720110",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720110_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fenofibrate\" outputclass=\"int-drug\">Fenofibrate</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust <ph otherprops=\"fenofibrate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/fenofibrate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP1686\">fenofibrate</xref></ph> dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fenofibrate   is predicted to   increase   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises adjust  fenofibrate  dose .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fenofibrate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720111",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720111_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"flucloxacillin\" outputclass=\"int-drug\">flucloxacillin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  flucloxacillin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flucloxacillin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720112",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720112_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"fluconazole\" outputclass=\"int-drug\">fluconazole</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  fluconazole  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720112_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluconazole\" outputclass=\"int-drug\">Fluconazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "2",
							"hasTextContent": "Fluconazole   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720113",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720113_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fusidic acid\" outputclass=\"int-drug\">Fusidic acid</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fusidic acid   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fusidic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720114",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720114_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"gemfibrozil\" outputclass=\"int-drug\">Gemfibrozil</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Gemfibrozil   increases   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gemfibrozil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720115",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720115_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"glecaprevir\" outputclass=\"int-drug\">Glecaprevir</ph> <ph outputclass=\"int-substanceQualifier\">(with pibrentasvir)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Glecaprevir   (with pibrentasvir)   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glecaprevir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720116",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720116_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Mild\" outputclass=\"int-message\">\n  <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">Fluvastatin</ph> <ph outputclass=\"int-magnitude\">slightly</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"glibenclamide\" outputclass=\"int-drug\">glibenclamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Mild",
							"hasOrder": "1",
							"hasTextContent": "Fluvastatin   slightly   increases   the exposure to   glibenclamide .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Glibenclamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720117",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720117_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"grazoprevir\" outputclass=\"int-drug\">Grazoprevir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/fluvastatin.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP1636\">fluvastatin</xref></ph> dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Grazoprevir   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises adjust  fluvastatin  dose .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Grazoprevir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720118",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720118_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"isavuconazole\" outputclass=\"int-drug\">Isavuconazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Isavuconazole   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isavuconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720119",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720119_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"isoniazid\" outputclass=\"int-drug\">isoniazid</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  isoniazid  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Isoniazid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720120",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720120_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"itraconazole\" outputclass=\"int-drug\">itraconazole</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  itraconazole  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Itraconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720121",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720121_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ledipasvir\" outputclass=\"int-drug\">Ledipasvir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ledipasvir   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ledipasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720122",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720122_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"leflunomide\" outputclass=\"int-drug\">leflunomide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  leflunomide  can increase the risk of hepatotoxicity. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720122_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"leflunomide\" outputclass=\"int-drug\">Leflunomide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Leflunomide   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Leflunomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720123",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720123_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"lenalidomide\" outputclass=\"int-drug\">lenalidomide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  lenalidomide  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lenalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720124",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720124_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"letermovir\" outputclass=\"int-drug\">Letermovir</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Letermovir   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Letermovir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720125",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720125_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"lomitapide\" outputclass=\"int-drug\">lomitapide</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  lomitapide  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lomitapide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720126",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720126_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"lymecycline\" outputclass=\"int-drug\">lymecycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  lymecycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lymecycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720127",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720127_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"mercaptopurine\" outputclass=\"int-drug\">mercaptopurine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  mercaptopurine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mercaptopurine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720128",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720128_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"methotrexate\" outputclass=\"int-drug\">methotrexate</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  methotrexate  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methotrexate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720129",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720129_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"micafungin\" outputclass=\"int-drug\">micafungin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  micafungin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Micafungin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720130",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720130_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"miconazole\" outputclass=\"int-drug\">Miconazole</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Miconazole   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Miconazole</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720131",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720131_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"minocycline\" outputclass=\"int-drug\">minocycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  minocycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Minocycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720132",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720132_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"nicotinic acid\" outputclass=\"int-drug\">Nicotinic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of rhabdomyolysis when given with</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Nicotinic acid   is predicted to   increase   the risk of rhabdomyolysis when given with   fluvastatin .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nicotinic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720133",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720133_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"oxytetracycline\" outputclass=\"int-drug\">oxytetracycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  oxytetracycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxytetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720134",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720134_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"paracetamol\" outputclass=\"int-drug\">paracetamol</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  paracetamol  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paracetamol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720135",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720135_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"paritaprevir\" outputclass=\"int-drug\">Paritaprevir</ph> <ph outputclass=\"int-substanceQualifier\">(with ritonavir and ombitasvir)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Paritaprevir   (with ritonavir and ombitasvir)   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "49",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paritaprevir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720136",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720136_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"pegaspargase\" outputclass=\"int-drug\">pegaspargase</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  pegaspargase  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "50",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pegaspargase</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720137",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720137_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"pibrentasvir\" outputclass=\"int-drug\">Pibrentasvir</ph> <ph outputclass=\"int-substanceQualifier\">(with glecaprevir)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Pibrentasvir   (with glecaprevir)   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "51",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pibrentasvir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720138",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720138_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"regorafenib\" outputclass=\"int-drug\">Regorafenib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor side effects</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Regorafenib   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises monitor side effects .    \n\n"
						}
					],
					"hasOrder": "52",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Regorafenib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720139",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720139_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rifampicin\" outputclass=\"int-drug\">Rifampicin</ph> <ph outputclass=\"int-magnitude\">moderately</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rifampicin   moderately   decreases   the exposure to   fluvastatin .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "53",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rifampicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720140",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720140_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sacubitril\" outputclass=\"int-drug\">Sacubitril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sacubitril   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "54",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sacubitril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720141",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720141_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"streptozocin\" outputclass=\"int-drug\">streptozocin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  streptozocin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "55",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptozocin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720142",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720142_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"sulfasalazine\" outputclass=\"int-drug\">sulfasalazine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  sulfasalazine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "56",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulfasalazine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720143",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720143_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sulfinpyrazone\" outputclass=\"int-drug\">Sulfinpyrazone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sulfinpyrazone   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "57",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulfinpyrazone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720144",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720144_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tedizolid\" outputclass=\"int-drug\">Tedizolid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tedizolid   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "58",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tedizolid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720145",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720145_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"teriflunomide\" outputclass=\"int-drug\">Teriflunomide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Teriflunomide   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "59",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Teriflunomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720146",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720146_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"tetracycline\" outputclass=\"int-drug\">tetracycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  tetracycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "60",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tetracycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720147",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720147_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"tigecycline\" outputclass=\"int-drug\">tigecycline</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  tigecycline  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "61",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tigecycline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720148",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720148_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"trabectedin\" outputclass=\"int-drug\">trabectedin</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  trabectedin  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "62",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trabectedin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720149",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720149_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"valproate\" outputclass=\"int-drug\">valproate</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  valproate  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "63",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Valproate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720150",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720150_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"venetoclax\" outputclass=\"int-drug\">Venetoclax</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Venetoclax   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "64",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Venetoclax</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720151",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720151_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph> and <ph otherprops=\"vincristine\" outputclass=\"int-drug\">vincristine</ph> can increase the risk of hepatotoxicity.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  fluvastatin  and  vincristine  can increase the risk of hepatotoxicity. \n\n"
						}
					],
					"hasOrder": "65",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Vincristine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720152",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720152_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"voxilaprevir\" outputclass=\"int-drug\">Voxilaprevir</ph> <ph outputclass=\"int-substanceQualifier\">(with sofosbuvir and velpatasvir)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">fluvastatin</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Voxilaprevir   (with sofosbuvir and velpatasvir)   is predicted to   increase   the exposure to   fluvastatin .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "66",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Voxilaprevir</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720153",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2#bnf_i1557280720153_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluvastatin\" outputclass=\"int-heading-drug\">Fluvastatin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the anticoagulant effect of</ph> <ph otherprops=\"warfarin\" outputclass=\"int-drug\">warfarin</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor INR and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fluvastatin   increases   the anticoagulant effect of   warfarin .  Manufacturer advises monitor INR and adjust dose .    \n\n"
						}
					],
					"hasOrder": "67",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Warfarin</title>"
					}
				}
			],
			"hasSearchLabel": " Fluvastatin  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/fluvastatin-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Fluvastatin </title>"
			},
			"rdfs:label": "fluvastatin"
		}
	]
}